ACTEMRA, (tocilizumab) is a prescription drug used to treat patients with rheumatoid arthritis-— an autoimmune disease that causes pain, swelling, and stiffness in joints (RA), and giant cell arteritis (GCA). If you’ve been injured by Actemra, call us now.
ACTEMRA, (tocilizumab) is a prescription drug used to treat patients with rheumatoid arthritis-— an autoimmune disease that causes pain, swelling, and stiffness in joints (RA), and giant cell arteritis (GCA). If you've been injured by Actemra, call us now.
ACTEMRA, (tocilizumab) is a prescription drug used to treat patients with rheumatoid arthritis-— an autoimmune disease that causes pain, swelling, and stiffness in joints (RA), and giant cell arteritis (GCA). ACTEMRA works to treat RA by directly blocking the action of a protein in your body called interleukin-6 (IL-6). The lawsuits have claimed that unlike other popular RA drugs like ENBREL, ACTEMRA’s label fails to warn of the serious side effects possible as a result of taking this drug.
Taken intravenously or by injection, ACTEMRA has been used by more than 760,000 patients globally and generated sales of $1.7 billion last year. Manufactured by Roche(Genentech), ACTEMRA is their fifth highest-grossing drug.
The following serious and dangerous side effects have been reported by those taking ACTEMRA:
According to a recent study published by STAT, Genentech originally advertised ACTEMRA as a safer alternative to similar drugs such as Humira, Enbrel and Remicade. The allegations mention that the pharmaceutical company never mentioned any of the above stated adverse reactions in the warning label. They claimed that ACTEMRA was a breakthrough drug since it showed none of the risks usually associated with this type of treatment.
However, the investigation found that ACTEMRA potentially was involved in a total of 1,128 death cases that have been brought to the attention of the U.S. Food and Drug Administration (FDA). After examining over 500,000 adverse reaction reports, the researchers indicated they believed that that tocilizumab was consistently more dangerous than the competing medications currently available on the market.
Lawyers who brought the ACTEMRA litigation in court on behalf of the victim(s) allege that Genentech/Roche were purposely not upfront with both doctors and patients to mislead them into believing their drug was safer than other competitors on the market.
The lawsuits have mentioned several claims, such as failure to warn, negligence in releasing a defective product to the market and conspiracy.
CONTACT US TODAY
If you or a loved one has taken ACTEMRA and suffered an adverse side effect(s), it is important that you contact Gruber Law Offices immediately. Contact Gruber Law Offices today at (877)276-HURT for a free and confidential consultation.
fda.gov/newsevents/newsroom/pressannouncements/ucm559791.htm
https://statnews.com/2017/06/05/actemra-rheumatoid-arthritis-fda/
https://medslawsuit.com/news/actemra-deaths-victims-filed-lawsuit/
Injured?
Get help now!